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Abstract 
Rheumatoid arthritis is a chronic disease and belongs to the group of systemic connective 
tissue diseases having an autoimmune basis. The most commonly reported symptoms by 
patients are pain, swelling and difficulty moving the affected joints. The course of rheumatoid 
arthritis is different in the elderly, the onset of the disease in the elderly is more severe than in 
the young, and large proximal joints are primarily involved. Make a diagnosis as soon as 
possible and start treatment, the greater the chance of delaying disease progression and even 
remission, which will minimize disability. In the treatment of rheumatoid arthritis in the 
elderly, who often have co-morbidities and often mobility difficulties, the role of 
physiotherapist and nursing care is extremely important next to medical treatment.  The use of 
kinesitherapy allows you to increase the range of motion of the joints and maintain them in 
good functional condition. Physiotherapy, on the other hand, has analgesic and anti-
inflammatory effects. This effect is enhanced by properly selected pharmacological treatment, 
carried out with the help of disease-modifying drugs, anti-inflammatory drugs, 
glucocorticosteroids and biological drugs. 
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Introduction 
 With the progressive aging of the population, the percentage of geriatric patients is 
increasing among the entire population of chronically ill people. It is no different if you 
consider patients with rheumatic ailments, especially those suffering from Rheumatoid 
Arthritis (RA). Patients over 60 years age are characterized by the frequent occurrence of 
comorbidities related to cardiovascular systems, kidney dysfunctions or cancer, which may 
result in polypharmacy [1, 2]. 
In patients with RA, interdisciplinary treatment is important, and in the team working with the 
patient, apart from doctors, nurses and physiotherapists play an important role. 
Comprehensive treatment and rehabilitation of the patient is particularly important in the case 
of RA, because in the case of this disease, it is carried out from the beginning of the detection 
of the disease to the end of the patient's life [1,3]. Rehabilitation of the patient is not only a 
medical but also a social process. His main task is to ensure the most dignified life with a 
sense of social security and satisfaction. The aim of the comprehensive operation of the 
medical team is to restore physical and mental fitness in the widest possible spectrum and in 
the shortest possible time [2, 4]. 
 Due to the unknown aetiology of RA, today's treatment does not provide permanent 
cure. Treatment aims to achieve full and lasting remission, a condition in which arthritis is 
inhibited to such an extent that it does not (or only minimally) lead to further structural 
damage to the joint. In spite of this, scientific achievements in recent years, especially during 
the last twenty years, have allowed to develop more effective methods of treatment of RA. It 
is based on the use of biological treatment and the use of the most modern techniques used in 
rehabilitation. The condition for improvement is simultaneous analgesic action, regulating 
muscle tone and relieving stress through the use of kinesitherapy, physical therapy and 
orthopedic supplies [4, 5]. 
 
 Rheumatoid arthritis 
           Rheumatoid arthritis is a chronic connective tissue disease.  The disease is 
characterized by inflammatory arthritis, non-articular changes and systemic complications. 
Arthritis is associated primarily with pain, edema, as well as reduced mobility and morning 
stiffness. Progressive arthritis leads to joint surface damage, joint capsule fibrosis, 
contractures and even muscular atrophy. RA is usually destroit affecting the small joints of 
the hands and feet, but it mainly affects the younger group of patients. At an older age, the 
onset of the disease is more severe and the disease begins to develop in large proximal joints, 
primarily the knee and shoulder joints [22, 35].  
 The initial phase of the disease is manifested by a feeling of weakness, fatigue, loss of 
appetite and, consequently, loss of body weight. Radiological changes in the joints are 
invisible. Blood results (OB, C-reactive protein) they are often only slightly increased. As you 
can see the diagnosis of the disease in the initial phase is very complicated, because the 
symptoms may indicate many other diseases. Often, one of the characteristic symptoms is the 
pain and swelling of some (less often) small joints of the hands or feet. The disease most often 
affects the joints metacarpophalangeal, interphalangeal joints, thumb and wrist joints. Then, 
knee, ankle, shoulder, and toe joints, or even the cervical spine and elbow joints are occupied. 
A characteristic symptom of the disease is morning stiffness, where the pain is directly 
proportional to the stage of the disease. In non-articular rheumatoid arthritis, we may 
encounter muscular dystrophy, tenosynovitis and tendons, the formation of rheumatoid 
tumors or changes in internal organs [6]. 
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Rheumatoid arthritis is characterized by Steinbrocker with four clinical periods: 
1. early period (pain, swelling, swelling in the outline of the joints, morning stiffness, light 
osteoporosis), 
2. moderate changes (periarticular lesions, mainly interosseous muscle wasting, limited 
mobility in X-ray image, visible osteoporosis, subchondral bone destruction + all symptoms 
from period 1.), 
3. advanced changes (damage to joint structures, intensified all the above symptoms, clear 
changes in the X-ray image), 
4. end stage (all of the above symptoms, appearance of fibrous adhesions and stiffness of the 
joints) [8, 9]. 
 
Laboratory diagnosis of RA 
Diagnosis of RA is based on the ACR (American Collegium of Rheumatology) and EULAR 
(European League Against Rheumatism) classification. The following four categories belong 
to these criteria: I. localization of inflammation, II. indicators of inflammation, such as the 
CRP (C-reactive) protein and OB (Biernacki's reaction), III. serological tests and IV. duration 
of disease symptoms [10]. According to the ACR and EULAR classification, four laboratory 
tests can be distinguished: OB, CRP protein, rheumatoid factor in the IgM class and anti-
CCP. The presence of rheumatoid factor (RF) in the IgM class occurs in about 75-85% of 
people with RA and correlates with the severity of the disease in the case of already 
diagnosed RA and is also a prognostic factor [11]. Anti-CCP (antibodies directed against the 
citrullinated peptide) are detectable in the early stages of the inflammatory process involving 
the synovium of joints and are detected in patients with RA [12, 13]. 
In clinical practice, imaging techniques such as DEXA densitometry or QUS quantitative 
ultrasound are used to assess bone metabolic disorders, which allows you to specify bone 
mineral density (BMD) and microarchitecture, and thus bone mineral content and bone 
fragility [14]. Determination of biochemical indicators of bone remodeling provides important 
information that complements the results of bone mineral density (BMD) measurements. 
Bone mineral density, as a resultant of peak bone mass, determines the risk of skeletal threats 
over the years, while bone remodeling indices reflect the current metabolic state of the whole 
skeleton [15]. 
The new application of biochemical indicators of bone turnover is their use to understand the 
mechanism of action of new therapies (drugs) on bone tissue. The indicators of bone 
formation are: 
- bone alkaline phosphatase (BAP) which is synthesized by osteoblasts, examined by 
electrophoresis, precipitation, EIA (Enzyme Immunoassays) or ELISA (Enzyme-Linked 
Immunosorbent Assay), and the material for testing is serum [12, 16]; 
-osteocalcin (OC), which is classified by osteoblasts (there are many immunoreactive forms in 
the blood), is tested by means of RIA (Radio Immuno Assay), CLIA (Chemiluminescence 
immunoassays), ELISA and the material for testing is serum; 
-N-terminal pro-collagen propeptide I (PINP) and C-terminal pro-collagen propeptide I 
(PICP) are augmented by proliferating osteoblasts and fibroblasts, tested by means of RIA, 
ELISA and the material to be tested is serum; 
The -C-terminal telopeptide of type I collagen (CTx) is synthesized by the type I collagen-
containing tissues, examined by means of RIA, ELISA, and the material to be tested is urine 
(CTx α / β) and serum (CTx α); 
The N-terminal collagen type I (NTx) telopeptide is synthesized by type I collagen-containing 
tissues, tested with RIA, ELISA, CLIA, and the material to be tested is urine or serum; 
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-Doxypyridinoline (DPD) synthesized by bone and dentin (not present in collagen of cartilage 
and skin, and released only from the mature form of collagen type I), tested by HPLC (high-
performance liquid chromatography), ELISA, CLIA, material for the test is urine or serum; 
-pyridinium (PYD) synthesized by bones, cartilage, tendons and blood vessels (mainly in 
cartilage and bone collagen, and released only from the mature type I collagen), tested by 
HPLC and ELISA, and urine or serum; 
 -C-terminal pro-collagen type I (ICTP) propeptide, which is derived from bone and skin, is 
tested with RIA and the material to be tested is serum; 
- medium-chain or long-chain osteocalcin friability which is derived from bone, is tested by 
means of ELISA and the material to be tested is urine; 
- Renewaried acid phosphatase is derived from bone and blood, examined by colorimetry, 
RIA, ELISA, and plasma or serum for analysis; 
- cathepsin K which is derived from osteoclasts, is tested by ELISA and the material to be 
tested is plasma or serum. 
The clinical value of bone remodeling factors is limited by the problem of their proper use 
and proper interpretation of results (age, sex), as well as problems related to the sampling and 
the method of determination. The advantage of determining bone turnover rates over BMD 
measurement are very rapidly changing values in pathological states (metabolic bone 
diseases), as a result of immobilization and after treatment [12]. 
 
Epidemiology 
The incidence of RA varies depending on the population and ranges from 0.5% to 1.5%. A 
higher frequency of cases is noticeable in North America and North Europe. In Poland, the 
incidence rate is estimated at 1% of the population. The highest number of cases falls on the 
4-5 decade of life. The problem of RA often affects women who are sick 2-3 times more often 
than men. Rheumatoid arthritis often contributes to disability [7,17]. It is estimated that in 
30% of people with disabilities in the UK the cause of disability was RA and in Australia - 
32% [16]. Rheumatoid arthritis is associated with the presence of the HLA-DR4 antigen of 
the histocompatibility complex, whose presence may increase the risk of disease in the family 
[18, 19]. It has been shown that smoking increases the risk of RA three times, especially in 
men and people with a positive rheumatoid factor. The degree of loss of fitness increases with 
the duration of the disease [21]. 
 
Kinesitherapy in rheumatoid arthritis 
           Kinesitherapy is one of the most important parts of rehabilitation. Achieving the 
effectiveness of therapy is determined primarily by the individual selection of exercises and 
their systematic exercise, but it is also important to start the therapeutic process early before 
the process of fixed deformities in the motor system. The start of the improvement process 
allows to maintain the joints and muscles in a very good functional condition. An extremely 
important element of kinesitherapy is controlling compensatory processes that may result in 
the appearance of overloading and deformation [22].  
         The guidelines presented by the panel Ottawski inform that a functional role in the 
improvement should be played by functional kinesiotherapy, the aim of which is to restore 
movement patterns that are closest to physiology. The activation of appropriate compensation 
mechanisms is conditioned by the early initiation of proper movement training. In conclusion, 
it can be said that the role of the therapist is to choose appropriate exercises that will 
contribute to the patient's independence without causing traumatization of tissues [22].  
         Due to the immunological basis of inflammation in rheumatic diseases, the 
improvement procedure differs significantly from the treatment of standard motor organ 
diseases. The kinesiotherapy tasks are focused primarily on the nourishment of joint cartilage 
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and increasing the range of movements. For this purpose, the therapist recommends passive 
exercise, self-assisted, active, free, relieved, and also with resistance. An important element is 
also the elimination of contractures, where mobilizations using manual techniques and 
extracts are used. In rheumatoid arthritis, attention is also paid to restoring normal muscle 
work through isometric exercises, resistance exercises and water exercises [23].  
 
Kinesitherapy methods 
         Currently, physiotherapeutic techniques are used, such as stretching, manual therapy 
techniques, soft tissue techniques (trigger point therapy, muscle straps, fascia techniques), as 
well as proprioceptive neuromuscular facilitation (PNF) [23]. Physiotherapists often benefit 
from proprioceptive neuromuscular facilitation, through the use of compression techniques, 
stretching, optimally adapted resistance, it improves the functioning of joints and 
neuromuscular coordination, develops muscular fitness and endurance [24].  
 
Physical methods 
In the comprehensive treatment of people with RA, it is crucial to use a therapy consisting of 
physiotherapy (massage, kinesitherapy, physical therapy) and pharmacotherapy. The main 
goal of physical therapy is to support properly selected pharmacological treatment and 
treatment of movement by analgesic and anti-inflammatory effects. This contributes to 
inhibition, control of the development of the disease course and reduction of patient's pain. 
Geriatric patients belong to the group that complains about the strongest pain in the 
course     of RA. This is mainly due to the duration of the disease and other comorbidities [25, 
26].  
Physiotherapeutic methods that, according to research, bring the best results in eliminating 
pain are: thermotherapy (local cryotherapy), magnetotherapy, ultrasound, laser biostimulation 
and TENS electrostimulation. According to the study [25] after the two-week treatment 
period, analgesic effects of physiotherapeutic treatments were observed in all patients 
participating in the study. The morning stiffness, whose length before the test was 1 hour and 
35 minutes, shortened its time and amounted to an average of 42 minutes. In addition, as a 
result of the impact of physical treatments, there is a reduction in joint swelling, which 
significantly improves the daily functioning of patients. According to Janiszewski et al., 
physical impact causes a secondary increase in muscle strength and improvement of muscular 
economics [26].  
In a study conducted by R. Skalska-Izdebska et al. [25], ultrasound therapy caused a decrease 
in pain in 92% of the patients. The action of the ultrasonic wave was confirmed in the 
literature by Konrad regarding the treatment of "rheumatoid hands", in which the best 
parameters of the treatments were: intensity 0.5-1.2 W / cm2 and frequency 800 Hz. The low 
frequency magnetic field at frequencies of 5-50 Hz and 10 Hz intensity resulted in reduction 
of symptoms in 70% of patients participating in the study. The Dortch and Johnson 
publications confirm the analgesic effect of this procedure. The electrostimulation 
recommended in the course of RA includes TENS and DD. Mika and Nowotny recommend 
the use of a sequence of diadynamic currents for analgesic purposes: DF-2 min, CP-3 min, 
LP-3 min [25, 26]. 
Cryotherapy, according to the study, is considered by patients with RA as the subjectively the 
most effective physiotherapeutic method in pain relief. The study [2] reported a reduction in 
pain in 86% of patients, indicating a therapeutic effect to reduce the sensation of pain. The 
positive effect of cryotherapy has been demonstrated in the literature by Miller, Michalik and 
Zagrobelny. They proved that this treatment has the effect of reducing pain and increasing 
blood flow through the skin and internal organs [27, 28].  
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Physiotherapy in geriatric patients is an important element in the treatment of RA due to its 
analgesic and anti-edematous action. The key is individual adjustment of doses and time of 
the treatment, individually tailored to the patient's ailments and condition. In addition, when 
choosing treatments, pay attention to contraindications that may occur when planning 
physical therapy for the elderly [29].  
 
Orthopedic supplies in RA  
The most commonly type of orthopedic supplies used in the conservative treatment of RA are 
orthoses and auxiliaries. The main purpose of using orthoses is prevention and treatment of 
deformity, joint stabilization, relief, pain reduction and prevention of contractures. On the 
other hand, auxiliary means usually serve to facilitate movement and prevent falls [3]. 
Spine orthoses can be divided due to the fuctions they are supposed to meet. There are 
stabilizing, relieving, immobilizing, corrective and functional corrective orthoses. A special 
case of supplies used by RA patientsorthosis is used in the presence of rheumatoid hand.Two 
types of such devices are mentioned: resting and functional. At rest, they serve the passive 
support of the hand, immobilizing the wrist and wrist joint in the neutral position. The 
functional task is to mobilize the hand and fingers for movement. In addition, RA patients 
often use mobility devices, such as crutches, walking sticks or walkers [10]. There are three 
types of crutches: elbow, axillary and crutches for rheumatics. Selection of crutches should 
take into account the degree of joint damage. Elbow crutches are usually the first choice in the 
early stages of the disease when there is still the possibility of additional load on the joints of 
the upper limbs, when it is not possible, axillary crutches are recommended. Patients use 
orthopedic beds and special accessories to facilitate daily activities, such as cutlery with a 
thickened grip, a device for loosening bottles or buckets [29]. Foot deformities with which 
patients with RA often face require careful selection of footwear and the use of specialist 
insoles tailored to the patient's needs. 
 
Pharmacological treatment in RA 
      The most important issue in the treatment of RA is rapid diagnosis. This allows you to 
obtain a time when you can choose an effective, individual treatment tailored to the patient's 
needs. There is a growing chance of getting remission and improving the patient's state of 
health. [30]. The most beneficial for the patient is to start treatment for a maximum of 6 
months from the diagnosis made. The sooner the therapy is started, the greater the chance of 
reducing the symptoms of RA and the remission of this disease. Early supply of drugs delays 
the development of a full-blown disease. This prevents damage to the joints and resulting 
disability. Disease-modifying anti-rheumatic drugs (DMARD) or combination therapy with 
high escalation should be used to achieve suppression of the disease [31]. Each patient may 
react differently to the treatment. It depends on the severity of the disease, genetic factors and 
other individual variations. Genetic factors are of particular importance in the selection of 
therapy. Despite the developed methods of treatment of RAs, the selection of personalized 
therapy is based on the trial and error method [32].  
       The basic drugs used to treat RA can be divided into: disease-modifying, biological, non-
steroidal anti-inflammatory drugs and glucorticosteroids. Key therapeutic agents are disease-
modifying drugs, which aim to reduce synovitis and systemic inflammation. In addition, they 
improve joint function. The most commonly used disease modifying drug is Methotrexat, 
which can be combined with other drugs of this type, e.g. eflunomide, sulfasalazine, anti-
malarial drugs and gold salts [33, 34]. Other groups of drugs used in the treatment of RA are 
glucorticosteroids, e.g. prednisolone, methylprednisolone and NSAIDs, their main task is to 
reduce inflammation and alleviate pain. These drugs should be used for a short time and only 
in the acute phase of the disease, because they affect the functioning of many organs and the 
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immune system [36]. In the absence of improvement in the treatment of RA with standard 
disease-modifying drugs, a biological drug is additionally included. Biological drugs also 
modify the course of the disease. Biological agents include monoclonal antibodies and 
receptors that result from genetic modification. They are used to block cytokines that 
stimulate inflammatory factors, and work at different levels. One of the major cytokines that 
is associated with the inflammatory process is tumor necrosis factor α (TNF-α). The main 
biological drugs used in RA are: adalimumab, anakinra, etanercept, golimumab, infiximab, 
tocylizumab, abatacept, and rituximab. Combination therapy with two or more DMARDs is 
more effective than a single drug. When used in combination therapy, especially in the 
elderly, side effects may increase more [33, 35, 37]. 
         Pharmacotherapy of RA in elderly people is often difficult due to concomitant diseases 
and involution changes, which affects the absorption, metabolism and elimination of the drug. 
Older people are advised to use lower doses of medication, especially since the same 
therapeutic effect will be achieved. In patients between 65 and 75 years of age the dose should 
be reduced by 10% between 75 and 85 years of age by 20%, and in patients over 85 years old 
by 30% [35]. 
 
Nursing care for a patient with Rheumatoid Arthritis 
Rheumatoid Arthritis is a disease that dramatically changes the quality of everyday life of 
people struggling with this disorder. Patients must learn how to deal with pain and limitations 
in terms of movements. The progress of the disease often prevents the patient from continuing 
his professional activity. In addition, patients with RA also suffer from mental disorders such 
as depression. Due to a number of problems that RA people have to deal with on a daily basis, 
comprehensive and professional nursing care is necessary to improve the quality of life of 
these patients [38]. 
One of the most important factors hindering everyday functioning of people with RA is 
chronic pain. It is caused by morning stiffness, swelling and joint deformities. Nursing care in 
this aspect over the patient should focus on the daily assessment of the severity and location 
of pain in the patient. This is possible through the use of NRS and VAS scales, as well as 
observation of nonverbal gestures on the part of the patient, which may suggest an increase in 
pain (muscle tension, facial grimace). It is also important to educate the patient about the use 
of warm compresses and baths, which belong to nonpharmacological methods of reducing 
pain. In addition, nursing staff should also monitor symptoms such as sleep disturbances, lack 
of appetite, significant mood depression, and fast fatigue in patients with RA. These 
symptoms are often a consequence of increased pain in the patient [39, 40]. 
Another problem of patients with RA, which requires help from nursing staff, is the self-care 
deficit, which is caused by a decrease in muscle strength and joint deformity. Support should 
then be provided to the patient, which will be adequate to the degree of this deficit. In the case 
when the patient is in a difficult position to change position, move, assist the patient in these 
activities, use auxiliary equipment such as sticks, crutches, balconies, trolley during the 
patient's movement. It is also important to properly motivate the patient to perform everyday 
activities as much as he / she can. Educating both the patient and his family about the 
adaptation of the apartment to the patient's needs. Providing tips on the organization of 
everyday life, to perform activities that require more physical activity while the action of 
painkillers will be greatest [39]. 
Rheumatoid arthritis often occurs in people over 60 years of age. In the case of caring for 
such a patient with RA, it is also important to observe complications related to 
pharmacological treatment. Older people who usually suffer from additional illnesses, such as 
diabetes, hypertension, require more urgent supervision from nurses or carers. It is necessary 
to educate the patient as well as his family about the side effects of medications that the 
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patient is taking, and the appropriate doses, the hours of taking medication. It is also 
important to develop a habit of controlling the basic vital parameters - blood pressure, heart 
rate, blood glucose and their proper recording. In addition, nursing staff should encourage 
physical activity to the extent appropriate to their current state so that they can maintain their 
fitness and independence for as long as possible [39]. 
Conclussions 
 Rheumatoid arthritis is one of the most complex autoimmune diseases that affects 
cartilage and bone tissue, causing systemic changes. Elderly patients are one of the most 
vulnerable groups for RA. The consequence of this disease may be joint deformities that 
cause disability or even death. Patients with RA should be treated interdisciplinary, due to the 
fact that this disease is  not only physically but also mentally. In the diagnosis of RA, studies 
of rheumatoid factor in the IgM class, anti-CCP and CRP (C-reactive) concentration and ESR 
is used. 
 Kinesitherapy and physical therapy play an important role in the effective treatment of 
RA. Kinesitherapy affects the maintenance of joints and muscles in a very good functional 
condition. Her tasks include nutrition of joint cartilage and increasing the range of motion. To 
achieve the intended effects, kinesitherapy exercises must be individually selected for the 
patient, and the patient should perform them systematically. In addition to kinesitherapy, 
physiotherapy is extremely important, which through analgesic and anti-inflammatory effects, 
which contributes to the inhibition and control of the disease and supports properly selected 
pharmacological treatment. Thermotherapy, magnetotherapy, ultrasounds, cryotherapy, laser 
biostimulation and TENS electrostimulation are considered the most effective methods of 
physical therapy. 
The use of orthoses by people with RA can be used to prevent and treat distortion, by 
stabilizing joints, relieving stress, reducing pain, which is most often reported by geriatric 
patients or the prevention of contractures. 
In the treatment of RA, the most commonly used disease-modifying drugs, the operator of 
which is Methotrexat, combining with painkillers. Unfortunately, this treatment does not 
achieve the desired effect in all patients. In recent years, treatment options for RA patients 
have increased, treatment of rheumatic diseases has revolutionized biological drugs. However, 
due to possible side effects, it cannot be used for all patients, special attention should be paid 
to the elderly. 
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